
SPH secures PACELINE grant, investigator shares his own cancer journey
“I thought that my story would offer hope to other cancer patients and cancer survivors because I’ve learned a lot about treatment options,” says Steven Coughlin, PhD.
Augusta University plans to expand its animation program to include an additional 21 faculty members in the Department of Art and Design, which will make it possible to attract about 400 more animation students in the coming years.

“I thought that my story would offer hope to other cancer patients and cancer survivors because I’ve learned a lot about treatment options,” says Steven Coughlin, PhD.




“I thought that my story would offer hope to other cancer patients and cancer survivors because I’ve learned a lot about treatment options,” says Steven Coughlin, PhD.




“I hope that our community can continue to honor those who made the ultimate sacrifice on 9/11 by honoring our commitment to #neverforget,” says John Ryan.



TUNE IN






STAY INFORMED
Jag Mobile is a one-stop virtual location for all need-to-know information and a centralized resource for other apps. This will include news and alerts, department updates, emergency information, health resources, student updates and more.
Stay connected and download “Jag Mobile by AU” today!
The annual event was held Sept. 7 on the Summerville Campus.

The book is designed for current instructors of public administration, political science and social science.

Corrina Warner, former interim vice president of finance and chief financial officer has been named Augusta University’s vice president of finance.

MCG scientists have early evidence that HBI-002, a low-dose oral compound developed by Hillhurst Biopharmaceuticals, can safely reduce oxidative stress and inflammation in the retina.

She chaired the society’s Public Relations Committee from 2016-19 and its Membership Committee from 2019-20.

Adams is the 2020 College of Science and Mathematics Distinguished Alumna and the global head of Biopharmaceutical Product Sciences and Device Development at GlaxoSmithKline.













